Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lotus Pharmaceutical Co Ltd gets FDA approval for Mefenamic Acid (250mg Capsule)


Monday, 4 Aug 2014 05:42am EDT 

Lotus Pharmaceutical Co Ltd:Got Food and Drug Administration approval for its new drug Mefenamic Acid (250mg Capsule) and to begin selling in August. 

Company Quote

101.5
1.9 +1.91%
22 Dec 2014